Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Aging (Albany NY) ; 12(15): 15186-15195, 2020 08 12.
Article in English | MEDLINE | ID: covidwho-713796

ABSTRACT

Italy was the first European nation to be affected by COVID-19. The biggest cluster of cases occurred in Lombardy, the most populous Italian region, and elderly men were the population hit in the hardest way. Besides its high infectivity, COVID-19 causes a severe cytokine storm and old people, especially those with comorbidities, appear to be the most vulnerable, presumably in connection to inflammaging. In centenarians inflammaging is much lower than predicted by their chronological age and females, presenting survival advantage in almost all centenarian populations, outnumber males, a phenomenon particularly evident in Northern Italy. Within this scenario, we wondered if: a) the COVID-19 mortality in centenarians was lower than that in people aged between 50 and 80 and b) the mortality from COVID-19 in nonagenarians and centenarians highlighted gender differences.We checked COVID-19-related vulnerability/mortality at the peak of infection (March 2020), using data on total deaths (i.e. not only confirmed COVID-19 cases). Our conclusion is that excess mortality increases steadily up to very old ages and at the same time men older than 90 years become relatively more resilient than age-matched females.


Subject(s)
Aging , Betacoronavirus/physiology , Coronavirus Infections , Health Services for the Aged/statistics & numerical data , Inflammation , Mortality , Pandemics , Pneumonia, Viral , Age Factors , Aged , Aged, 80 and over , Aging/physiology , Aging/psychology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Coronavirus Infections/therapy , Female , Health Services Needs and Demand , Health Status Disparities , Humans , Inflammation/epidemiology , Inflammation/virology , Italy/epidemiology , Male , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/therapy , Public Health/methods , SARS-CoV-2 , Sex Factors , Vulnerable Populations
SELECTION OF CITATIONS
SEARCH DETAIL